Bendamustine is a bifunctional alkylating agent of the nitrogen mustard class indicated for the treatment of chronic lymphocytic leukemia, non-Hodgkin's lymphoma, and multiple myeloma. It exerts its therapeutic… Read more
























![Chemical structure of Ethyl 4-(5-((2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1366085-72-4-Ethyl-4-5-2-hydroxyethylamino-1-methyl-1H-benzodimidazol-2-ylbutanoate.png&w=3840&q=75)
![Chemical structure of Ethyl 4-(6-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1469343-10-9-Ethyl-4-6-amino-1-methyl-1H-benzodimidazol-2-ylbutanoate.png&w=3840&q=75)


![Chemical structure of Isopropyl 4-(5-((2-hydroxyethyl)(methyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FIsopropyl-4-5-2-hydroxyethylmethylamino-1-methyl-1H-benzodimidazol-2-ylbutanoate.png&w=3840&q=75)











Bendamustine is a bifunctional alkylating agent of the nitrogen mustard class indicated for the treatment of chronic lymphocytic leukemia, non-Hodgkin's lymphoma, and multiple myeloma. It exerts its therapeutic effects by forming intra- and inter-strand DNA cross-links, which inhibit replication and transcription in cancer cells. To support rigorous quality control and regulatory compliance, pharmaceutical laboratories require high-quality reference standards for Bendamustine, including its pharmacopeial and non-pharmacopeial impurities, degradation products, and related compounds. These standards are essential for comprehensive impurity profiling, stability testing, and analytical method validation to monitor process-related contaminants. Furthermore, stable isotope labelled compounds are indispensable in advanced analytical chemistry, serving as precise internal standards for accurate quantification in LC-MS/MS studies. By utilizing these characterized reference materials, researchers can effectively identify and control impurities arising during synthesis or storage, ensuring consistent drug safety and efficacy.